Steril-Gene Life Sciences Private Limited - Company Profile

It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2007.
2007 Chennai, Tamil Nadu, India Active
Last Updated:
Access Report
About Steril-Gene Life Sciences Private Limited

Steril-Gene Life Sciences Private Limited, a active private limited company, was established on 28 February 2007 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U02423TN2007PTC062549. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹216.00 Cr and a paid-up capital of ₹212.64 Cr.

Formerly known as Sterigene Life Sciences Private Limited. It upholds a compliant status. Employing 957 professional, Its leadership includes Alagappan (Director), Lloyd Dizon Balajadia (Director), Dennis Dizon Balajadia (Director). Past directors included Sivasamy Manohar, Alagappan, Krishnamurthy Balakumar. It holds ₹374.75 Cr open charges and ₹148.02 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at New No.15, Old No.7, Gopalakrishnan Road, T. Nagar, Chennai, Tamil Nadu, 600017.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U02423TN2007PTC062549

  • Registration Number

    062549

  • Incorporation Date

    28 February 2007

  • Authorized Capital

    ₹216.00 Cr

  • Paid-Up Capital

    ₹212.64 Cr

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 216.00 Cr
  • Paid Up Capital ₹ 212.64 Cr
  • Company Age 19 Year, 1 Day
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 374.75 Cr
  • Satisfied Charges ₹ 148.02 Cr
  • Revenue Growth **** 21.76%
  • Profit Growth **** -421.99%
  • Ebitda **** -66.84%
  • Net Worth 170.03%
  • Total Assets -2.23%
Company report

Steril-Gene Life Sciences Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Steril-Gene Life Sciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Steril-Gene Life Sciences Private Limited?
Current Directors
Name Designation Appointment Date Status
Alagappan Director 10 Mar 2014 Current
Lloyd Dizon Balajadia Director 04 Dec 2009 Current
Dennis Dizon Balajadia Director 04 Dec 2009 Current
Sulaiman Abdulhai Mohammed Managing Director 28 Feb 2007 Current
Dick Dizon Balajadia Director 04 Dec 2009 Current
Manohar Srivignesh Director 14 Dec 2023 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 14 Dec 2023 Past
Pramod Abcsdd Additional Director 25 Sep 2014 Past
Pramod Abcsdd Additional Director 25 Sep 2014 Past
Pramod Abcsdd Additional Director 30 Sep 2010 Past
Pramod Abcsdd Additional Director 30 Sep 2010 Past
Pramod Abcsdd Director 10 Mar 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Steril-Gene Life Sciences.

Steril-Gene Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 21.76% increase. The company also saw a substantial fall in profitability, with a 421.99% decrease in profit. The company's net worth Soared by an impressive increase of 170.03%.

Steril-Gene Life Sciences revenue growth over time
Steril-Gene Life Sciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 21.76%
*******
*******
*******
*******
Revenue from Operations
*******
 22.36%
*******
*******
*******
*******
Total Assets
*******
 -2.23%
*******
*******
*******
*******
Profit or Loss
*******
 -421.99%
*******
*******
*******
*******
Net Worth
*******
 170.03%
*******
*******
*******
*******
EBITDA
*******
 -66.84%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Steril-Gene Life Sciences?

In 2023, Steril-Gene Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹3,747,500,000.00

Satisfied Charges

₹1,480,200,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 374.75 Cr
Latest Charge Details
Date Lender Amount Status
20 Jan 2025 Hdfc Bank Limited ₹20.00 Cr Open
17 May 2024 Hdfc Bank Limited ₹30.00 Cr Open
09 Jun 2023 Hdfc Bank Limited ₹120.00 Cr Open
17 Apr 2023 Hdfc Bank Limited ₹5.00 Cr Open
17 Apr 2023 Hdfc Bank Limited ₹9.00 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Steril-Gene Life Sciences?

Steril-Gene Life Sciences has a workforce of 957 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Steril-Gene Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Steril-Gene Life Sciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Steril-Gene Life Sciences
Recent Activity within the Organization
  • Charges

    Progress on A charge with Hdfc Bank Limited of Rs. 20.00 Cr registered on 20 Jan 2025 with Charge ID 101043873 was modified on 12 Feb 2025. was documented.

  • Charges

    Progress on A charge with Hdfc Bank Limited of Rs. 121.00 Cr registered on 31 Dec 2016 with Charge ID 100083924 was modified on 12 Feb 2025. was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 20.00 Cr with Charge ID 101043873 was registered on 20 Jan 2025. was completed.

  • Charges

    The activity A charge with Hdfc Bank Limited of Rs. 30.00 Cr registered on 17 May 2024 with Charge ID 100923262 was modified on 12 Nov 2024. was completed.

  • Annual General Meeting

    The activity Steril-Gene Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 30.00 Cr with Charge ID 100923262 was registered on 17 May 2024. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Steril-Gene Life Sciences Private Limited?

The CIN of Steril-Gene Life Sciences Private Limited is U02423TN2007PTC062549.

Where is Steril-Gene Life Sciences Private Limited headquartered?

Steril-Gene Life Sciences Private Limited is headquartered at New No.15, Old No.7, Gopalakrishnan Road, T. Nagar, Chennai, Tamil Nadu, 600017.

When was Steril-Gene Life Sciences Private Limited incorporated?

Steril-Gene Life Sciences Private Limited was incorporated on 28 February 2007.

Who are the current directors of Steril-Gene Life Sciences Private Limited?

The current directors of Steril-Gene Life Sciences Private Limited are

What is the primary industry of Steril-Gene Life Sciences Private Limited?

The primary industry of Steril-Gene Life Sciences Private Limited is Manufacturing.

Is Steril-Gene Life Sciences Private Limited a listed company?

Steril-Gene Life Sciences Private Limited is unlisted.

What is the capital structure of Steril-Gene Life Sciences Private Limited?

The authorized capital of Steril-Gene Life Sciences Private Limited is ₹216.00 Cr, and the paid-up capital is ₹212.64 Cr.

What is the compliance status of Steril-Gene Life Sciences Private Limited?

The compliance status of Steril-Gene Life Sciences Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available